228 related articles for article (PubMed ID: 33008333)
1. Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment.
Abong RA; Amambo GN; Chounna Ndongmo PW; Njouendou AJ; Ritter M; Beng AA; Esum ME; Deribe K; Fru-Cho J; Fombad FF; Nji TM; Enyong PI; Poole CB; Pfarr K; Hoerauf A; Carlow CKS; Wanji S
BMC Infect Dis; 2020 Oct; 20(1):726. PubMed ID: 33008333
[TBL] [Abstract][Full Text] [Related]
2. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.
Osei-Atweneboana MY; Awadzi K; Attah SK; Boakye DA; Gyapong JO; Prichard RK
PLoS Negl Trop Dis; 2011 Mar; 5(3):e998. PubMed ID: 21468315
[TBL] [Abstract][Full Text] [Related]
4. Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
Nana-Djeunga HC; Bourguinat C; Pion SD; Bopda J; Kengne-Ouafo JA; Njiokou F; Prichard RK; Wanji S; Kamgno J; Boussinesq M
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2824. PubMed ID: 24762816
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
Pion SD; Nana-Djeunga HC; Kamgno J; Tendongfor N; Wanji S; Njiokou F; Prichard RK; Boussinesq M
PLoS Negl Trop Dis; 2013; 7(2):e2084. PubMed ID: 23469307
[TBL] [Abstract][Full Text] [Related]
6. The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
Abong RA; Amambo GN; Hamid AA; Enow BA; Beng AA; Nietcho FN; Nji TM; Njouendou AJ; Ritter M; Esum ME; Deribe K; Cho JF; Fombad FF; Enyong PI; Poole C; Pfarr K; Hoerauf A; Carlow C; Wanji S
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008926. PubMed ID: 33465080
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
[TBL] [Abstract][Full Text] [Related]
8. The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
Nikièma AS; Koala L; Sondo AK; Post RJ; Paré AB; Kafando CM; Kambiré RS; Sow B; Bougouma C; Dabiré RK; Traoré S
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009117. PubMed ID: 33647010
[TBL] [Abstract][Full Text] [Related]
9. A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.
Opoku NO; Gyasi ME; Doe F; Lew D; Hong AR; Chithenga S; Fischer PU; King CL; Weil GJ
Am J Trop Med Hyg; 2021 Nov; 106(2):740-745. PubMed ID: 34844204
[TBL] [Abstract][Full Text] [Related]
10. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
[TBL] [Abstract][Full Text] [Related]
11. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.
Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Abong RA; Enyong P; Taylor DW
Parasit Vectors; 2015 Dec; 8():667. PubMed ID: 26715524
[TBL] [Abstract][Full Text] [Related]
12. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
13. Reductions in microfilaridermia by repeated ivermectin treatment are associated with lower Plasmodium-specific Th17 immune responses in Onchocerca volvulus-infected individuals.
Arndts K; Klarmann-Schulz U; Batsa L; Debrah AY; Epp C; Fimmers R; Specht S; Layland LE; Hoerauf A
Parasit Vectors; 2015 Mar; 8():184. PubMed ID: 25889652
[TBL] [Abstract][Full Text] [Related]
14. Modelling Neglected Tropical Diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings.
Bottomley C; Isham V; Vivas-Martínez S; Kuesel AC; Attah SK; Opoku NO; Lustigman S; Walker M; Basáñez MG
Parasit Vectors; 2016 Jun; 9(1):343. PubMed ID: 27301567
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline Leads to Sterility and Enhanced Killing of Female Onchocerca volvulus Worms in an Area With Persistent Microfilaridermia After Repeated Ivermectin Treatment: A Randomized, Placebo-Controlled, Double-Blind Trial.
Debrah AY; Specht S; Klarmann-Schulz U; Batsa L; Mand S; Marfo-Debrekyei Y; Fimmers R; Dubben B; Kwarteng A; Osei-Atweneboana M; Boakye D; Ricchiuto A; Büttner M; Adjei O; Mackenzie CD; Hoerauf A
Clin Infect Dis; 2015 Aug; 61(4):517-26. PubMed ID: 25948064
[TBL] [Abstract][Full Text] [Related]
16. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
[TBL] [Abstract][Full Text] [Related]
17. Onchocerca volvulus: striking decrease in transmission in the Vina valley (Cameroon) after eight annual large scale ivermectin treatments.
Boussinesq M; Prod'hon J; Chippaux JP
Trans R Soc Trop Med Hyg; 1997; 91(1):82-6. PubMed ID: 9093638
[TBL] [Abstract][Full Text] [Related]
18. Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone.
Koroma JB; Sesay S; Conteh A; Koudou B; Paye J; Bah M; Sonnie M; Hodges MH; Zhang Y; Bockarie MJ
Infect Dis Poverty; 2018 Apr; 7(1):30. PubMed ID: 29628019
[TBL] [Abstract][Full Text] [Related]
19. Onchocerciasis-associated epilepsy in the Democratic Republic of Congo: Clinical description and relationship with microfilarial density.
Siewe Fodjo JN; Mandro M; Mukendi D; Tepage F; Menon S; Nakato S; Nyisi F; Abhafule G; Wonya'rossi D; Anyolito A; Lokonda R; Hotterbeekx A; Colebunders R
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007300. PubMed ID: 31314757
[TBL] [Abstract][Full Text] [Related]
20. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis.
Basáñez MG; Pion SD; Boakes E; Filipe JA; Churcher TS; Boussinesq M
Lancet Infect Dis; 2008 May; 8(5):310-22. PubMed ID: 18471776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
